$ASCH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CURAXIS PHARMACEUTICAL Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CURAXIS PHARMACEUTICAL Corp. Get notifications about new insider transactions in CURAXIS PHARMACEUTICAL Corp for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2012 | ASCH | CURAXIS PHARMACEUT ... | WRIGHT TIMOTHY R | Chief Executive Off ... | Option Exercise | A | 0.01 | 500,000 | 5,500 | 800,000 | |
May 10 2012 | ASCH | CURAXIS PHARMACEUT ... | Geaslen Judith S.T. | VP - Finance | Option Exercise | A | 0.01 | 300,000 | 3,300 | 564,500 | |
Jan 24 2012 | ASCH | CURAXIS PHARMACEUT ... | Leary Stephen J | Director | Grant | A | 0.04 | 200,000 | 8,000 | 617,509 | 417.5 K to 617.5 K (+47.90 %) |
Jan 24 2012 | ASCH | CURAXIS PHARMACEUT ... | GEORGE MICHAEL W | Director | Grant | A | 0.04 | 200,000 | 8,000 | 409,229 | 209.2 K to 409.2 K (+95.59 %) |
Jan 24 2012 | ASCH | CURAXIS PHARMACEUT ... | Novak Terence | Director | Grant | A | 0.04 | 150,000 | 6,000 | 220,671 | 70.7 K to 220.7 K (+212.25 %) |
Jan 24 2012 | ASCH | CURAXIS PHARMACEUT ... | GOTHNER K IVAN F | Director | Grant | A | 0.04 | 150,000 | 6,000 | 220,671 | 70.7 K to 220.7 K (+212.25 %) |
Nov 21 2011 | ASCH | CURAXIS PHARMACEUT ... | Leary Stephen J | Director | Grant | A | 0.08 | 39,229 | 3,331 | 688,599 | 649.4 K to 688.6 K (+6.04 %) |
Nov 21 2011 | ASCH | CURAXIS PHARMACEUT ... | Leary Stephen J | Director | Grant | A | 0.08 | 55,000 | 4,670 | 649,370 | 594.4 K to 649.4 K (+9.25 %) |
Nov 21 2011 | ASCH | CURAXIS PHARMACEUT ... | GEORGE MICHAEL W | Director | Grant | A | 0.08 | 94,229 | 8,000 | 209,229 | 115 K to 209.2 K (+81.94 %) |
Nov 21 2011 | ASCH | CURAXIS PHARMACEUT ... | Novak Terence | Director | Grant | A | 0.08 | 70,671 | 6,000 | 70,671 | 0 to 70.7 K |
Nov 21 2011 | ASCH | CURAXIS PHARMACEUT ... | GOTHNER K IVAN F | Director | Grant | A | 0.08 | 70,671 | 6,000 | 70,671 | 0 to 70.7 K |
Nov 03 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Sell | S | 0.05 | 1,650,000 | 82,500 | 6,426,453 | 8.1 M to 6.4 M (-20.43 %) |
Oct 12 2011 | ASCH | CURAXIS PHARMACEUT ... | Geaslen Judith S.T. | Vice President - Fi ... | Gift | G | 0.00 | 25,000 | 0 | 244,800 | 219.8 K to 244.8 K (+11.37 %) |
Oct 12 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Gift | G | 0.00 | 25,000 | 0 | 8,076,453 | 8.1 M to 8.1 M (-0.31 %) |
Oct 12 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Sell | S | 0.05 | 820,000 | 41,000 | 8,101,453 | 8.9 M to 8.1 M (-9.19 %) |
Oct 12 2011 | ASCH | CURAXIS PHARMACEUT ... | GEORGE MICHAEL W | Director | Buy | P | 0.05 | 100,000 | 5,000 | 115,000 | 15 K to 115 K (+666.67 %) |
Oct 05 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Sell | S | 0.05 | 900,000 | 45,000 | 8,921,453 | 9.8 M to 8.9 M (-9.16 %) |
Oct 05 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Sell | S | 0.03 | 150,000 | 5,100 | 9,821,453 | 10 M to 9.8 M (-1.50 %) |
Oct 05 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Sell | S | 0.10 | 1,000,000 | 97,000 | 9,971,453 | 11 M to 10 M (-9.11 %) |
Sep 20 2011 | ASCH | CURAXIS PHARMACEUT ... | Leary Stephen J | Director | Buy | P | 0.05 | 100,000 | 5,000 | 544,370 | 444.4 K to 544.4 K (+22.50 %) |
Aug 17 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Sell | S | 0.10 | 350,000 | 35,000 | 10,971,453 | 11.3 M to 11 M (-3.09 %) |
Aug 17 2011 | ASCH | CURAXIS PHARMACEUT ... | Smith Patrick S | 10% Owner | Sell | S | 0.05 | 1,550,000 | 77,500 | 11,321,453 | 12.9 M to 11.3 M (-12.04 %) |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | Spilker Bert | Director | Option Exercise | A | 0.20 | 75,000 | 15,000 | 175,000 | |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | Novak Terence | Director | Option Exercise | A | 0.20 | 75,000 | 15,000 | 75,000 | |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | Miller Michael R | Director | Option Exercise | A | 0.20 | 75,000 | 15,000 | 75,000 | |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | GOTHNER K IVAN F | Director | Option Exercise | A | 0.20 | 75,000 | 15,000 | 75,000 | |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | GEORGE MICHAEL W | Director | Option Exercise | A | 0.20 | 75,000 | 15,000 | 75,000 | |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | Leary Stephen J | Director | Option Exercise | A | 0.20 | 75,000 | 15,000 | 75,000 | |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | Leary Stephen J | Director | Buy | P | 0.05 | 200,000 | 10,000 | 444,370 | 244.4 K to 444.4 K (+81.84 %) |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | Geaslen Judith S.T. | VP - Finance | Option Exercise | A | 0.20 | 50,000 | 10,000 | 264,500 | |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | Geaslen Judith S.T. | VP - Finance | Buy | P | 0.05 | 200,000 | 10,000 | 219,800 | 19.8 K to 219.8 K (+1,010.10 %) |
Aug 15 2011 | ASCH | CURAXIS PHARMACEUT ... | WRIGHT TIMOTHY R | Interim CEO | Option Exercise | A | 0.20 | 300,000 | 60,000 | 300,000 |
Page: 1